Physician

Sushma Tatineni, MD

According to 2025 Medicare claims, Sushma Tatineni, MD (NPI: 1659785988) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55435-2281. Tatineni is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Tatineni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 224 traditional Medicare patients, billed 48,123 HCPCS/CPT codes, and received $1,007,366 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 478 prescription claims across 89 beneficiaries totaling $1,589,994 in drug costs, led by Pomalyst (Pomalidomide). 2023 DME data shows 12 claims. Open Payments data shows 6 records totaling $8,690. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,491 to $1,007,366. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,011 to $1,589,994. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.